223 related articles for article (PubMed ID: 22101079)
21. Distribution of yeast isolates from invasive infections and their in vitro susceptibility to antifungal agents: evidence from 299 cases in a 3-year (2010 to 2012) surveillance study.
Li W; Hu YA; Li FQ; Shi LN; Shao HF; Huang M; Wang Y; Han DD; Liao H; Ma CF; Zhang GY
Mycopathologia; 2015 Jun; 179(5-6):397-405. PubMed ID: 25588889
[TBL] [Abstract][Full Text] [Related]
22. Fungemia in the French department of Mayotte, Indian Ocean: A 10 years survey.
Wankap R; Mogo C; Niang M; Diallo A; Balloy L; Baes L; Collet L; Benoit-Cattin T; Permal S; Guegan H; Gangneux JP
J Mycol Med; 2021 Mar; 31(1):101081. PubMed ID: 33360730
[TBL] [Abstract][Full Text] [Related]
23. Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility.
Arendrup MC; Fuursted K; Gahrn-Hansen B; Jensen IM; Knudsen JD; Lundgren B; Schønheyder HC; Tvede M
J Clin Microbiol; 2005 Sep; 43(9):4434-40. PubMed ID: 16145088
[TBL] [Abstract][Full Text] [Related]
24. The yeast species causing fungemia at a university hospital in Riyadh, Saudi Arabia, during a 10-year period.
Al-Hedaithy SS
Mycoses; 2003 Sep; 46(8):293-8. PubMed ID: 12950897
[TBL] [Abstract][Full Text] [Related]
25. Bloodstream infections by Malassezia and Candida species in critical care patients.
Iatta R; Cafarchia C; Cuna T; Montagna O; Laforgia N; Gentile O; Rizzo A; Boekhout T; Otranto D; Montagna MT
Med Mycol; 2014 Apr; 52(3):264-9. PubMed ID: 24576998
[TBL] [Abstract][Full Text] [Related]
26. Invasive fungal infections in Chile: a multicenter study of fungal prevalence and susceptibility during a 1-year period.
Silva V; Díaz MC; Febré N;
Med Mycol; 2004 Aug; 42(4):333-9. PubMed ID: 15473358
[TBL] [Abstract][Full Text] [Related]
27. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
28. Emerging opportunistic yeast infections.
Miceli MH; Díaz JA; Lee SA
Lancet Infect Dis; 2011 Feb; 11(2):142-51. PubMed ID: 21272794
[TBL] [Abstract][Full Text] [Related]
29. In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study.
Wang H; Xiao M; Chen SC; Kong F; Sun ZY; Liao K; Lu J; Shao HF; Yan Y; Fan H; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Xu YC
J Clin Microbiol; 2012 Dec; 50(12):3952-9. PubMed ID: 23035204
[TBL] [Abstract][Full Text] [Related]
30. Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study.
Minea B; Nastasa V; Moraru RF; Kolecka A; Flonta MM; Marincu I; Man A; Toma F; Lupse M; Doroftei B; Marangoci N; Pinteala M; Boekhout T; Mares M
Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):367-83. PubMed ID: 25224578
[TBL] [Abstract][Full Text] [Related]
31. Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.
Pfaller MA; Messer SA; Woosley LN; Jones RN; Castanheira M
J Clin Microbiol; 2013 Aug; 51(8):2571-81. PubMed ID: 23720791
[TBL] [Abstract][Full Text] [Related]
32. [Yeast infections: causative agents and their antifungal resistance in hospitalized pediatric patients and HIV-positive adults].
Rodero L; Boutureira M; Demkura H; Burkett A; Fernández C; Losso M; Jáuregui Rueda H; Monticelli A; Vitale R; Canteros C; Hochenfellner F; Vivot W; Davel G
Rev Argent Microbiol; 1997; 29(1):7-15. PubMed ID: 9229726
[TBL] [Abstract][Full Text] [Related]
33. Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol.
Krcmery V; Mateicka F; Kunová A; Spánik S; Gyarfás J; Sycová Z; Trupl J
Support Care Cancer; 1999 Jan; 7(1):39-43. PubMed ID: 9926973
[TBL] [Abstract][Full Text] [Related]
34. Multidrug resistant yeasts in synanthropic wild birds.
Lord AT; Mohandas K; Somanath S; Ambu S
Ann Clin Microbiol Antimicrob; 2010 Mar; 9():11. PubMed ID: 20307325
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R
Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550
[TBL] [Abstract][Full Text] [Related]
36. Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002-14).
Bretagne S; Renaudat C; Desnos-Ollivier M; Sitbon K; Lortholary O; Dromer F;
J Antimicrob Chemother; 2017 Jun; 72(6):1784-1793. PubMed ID: 28333259
[TBL] [Abstract][Full Text] [Related]
37. Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center.
Marcos-Zambrano LJ; Escribano P; Sánchez C; Muñoz P; Bouza E; Guinea J
Antimicrob Agents Chemother; 2014 Aug; 58(8):4565-72. PubMed ID: 24867979
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.
Almirante B; Rodríguez D; Park BJ; Cuenca-Estrella M; Planes AM; Almela M; Mensa J; Sanchez F; Ayats J; Gimenez M; Saballs P; Fridkin SK; Morgan J; Rodriguez-Tudela JL; Warnock DW; Pahissa A;
J Clin Microbiol; 2005 Apr; 43(4):1829-35. PubMed ID: 15815004
[TBL] [Abstract][Full Text] [Related]
39. Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011.
Guinea J; Zaragoza Ó; Escribano P; Martín-Mazuelos E; Pemán J; Sánchez-Reus F; Cuenca-Estrella M;
Antimicrob Agents Chemother; 2014; 58(3):1529-37. PubMed ID: 24366741
[TBL] [Abstract][Full Text] [Related]
40. Hematogenous infections due to Candida parapsilosis: changing trends in fungemic patients at a comprehensive cancer center during the last four decades.
Safdar A; Perlin DS; Armstrong D
Diagn Microbiol Infect Dis; 2002 Sep; 44(1):11-6. PubMed ID: 12376025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
